These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1486749

  • 1. Human parvovirus B19 and rheumatoid arthritis.
    Taylor HG, Borg AA, Dawes PT.
    Clin Rheumatol; 1992 Dec; 11(4):548-50. PubMed ID: 1486749
    [Abstract] [Full Text] [Related]

  • 2. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T.
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [Abstract] [Full Text] [Related]

  • 3. Human parvovirus B19-associated arthritis in children.
    Nocton JJ, Miller LC, Tucker LB, Schaller JG.
    J Pediatr; 1993 Feb; 122(2):186-90. PubMed ID: 8429430
    [Abstract] [Full Text] [Related]

  • 4. Association between human parvovirus B19 infection and arthritis.
    Cassinotti P, Bas S, Siegl G, Vischer TL.
    Ann Rheum Dis; 1995 Jun; 54(6):498-500. PubMed ID: 7632094
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA, Leslie EE, Smith S, O'Neill HJ, Hart H, Cohen BJ, Inglis JM.
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [Abstract] [Full Text] [Related]

  • 6. Parvovirus B19 infection and idiopathic thrombocytopenic purpura.
    van Elsacker-Niele AM, Weiland HT, Kroes AC, Kappers-Klunne MC.
    Ann Hematol; 1996 Mar; 72(3):141-4. PubMed ID: 8766256
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis for human parvovirus B19-polyarthritis: usefulness of empty particle B19.ELISA and B19-DNA.PCR].
    Hatakeyama Y, Ishii K, Murai C, Sugamura K, Mitomo N, Saitoh T, Rikimaru Y, Okazaki T, Sasaki T.
    Ryumachi; 1998 Oct; 38(5):689-95. PubMed ID: 9852745
    [Abstract] [Full Text] [Related]

  • 8. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR, Coyle PV, DeLeys RJ, Patterson CC.
    J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
    [Abstract] [Full Text] [Related]

  • 9. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis.
    Kishore J, Misra R, Gupta D, Ayyagari A.
    Indian J Med Res; 1998 Jan; 107():15-8. PubMed ID: 9529776
    [Abstract] [Full Text] [Related]

  • 10. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
    Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, MacGregor RR, Friedman HM.
    Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
    [Abstract] [Full Text] [Related]

  • 11. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ.
    J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
    [Abstract] [Full Text] [Related]

  • 12. Parvovirus B19 outbreak in a developmental center.
    Lohiya GS, Stewart K, Perot K, Widman R.
    Am J Infect Control; 1995 Dec; 23(6):373-6. PubMed ID: 8821114
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.
    Cubel RC, Oliveira SA, Brown DW, Cohen BJ, Nascimento JP.
    J Clin Microbiol; 1996 Jan; 34(1):205-7. PubMed ID: 8748306
    [Abstract] [Full Text] [Related]

  • 14. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF, Paula WN, Cubel Rde C, Nascimento JP.
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [Abstract] [Full Text] [Related]

  • 15. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [Abstract] [Full Text] [Related]

  • 16. Established fibromyalgia syndrome and parvovirus B19 infection.
    Berg AM, Naides SJ, Simms RW.
    J Rheumatol; 1993 Nov; 20(11):1941-3. PubMed ID: 8308782
    [Abstract] [Full Text] [Related]

  • 17. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19.
    Kakurina N, Kadisa A, Lejnieks A, Mikazane H, Kozireva S, Murovska M.
    Medicina (Kaunas); 2015 Nov; 51(1):18-24. PubMed ID: 25744771
    [Abstract] [Full Text] [Related]

  • 18. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19.
    Yaegashi N, Okamura K, Tsunoda A, Nakamura M, Sugamura K, Yajima A.
    J Infect; 1995 Nov; 31(3):195-200. PubMed ID: 8586838
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
    Mimori A, Misaki Y, Hachiya T, Ito K, Kano S.
    Rheumatol Int; 1994 Nov; 14(3):87-90. PubMed ID: 7839075
    [Abstract] [Full Text] [Related]

  • 20. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).
    Chou TN, Hsu TC, Chen RM, Lin LI, Tsay GJ.
    Lupus; 2000 Nov; 9(7):551-4. PubMed ID: 11035424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.